Sat.Feb 13, 2021 - Fri.Feb 19, 2021

article thumbnail

LSD biotech MindMed buys digital trial firm HealthMode

pharmaphorum

Psychedelic medicine biotech MindMed is to acquire digital medicine and therapeutics startup HealthMode for around $32.2 million, which uses artificial intelligence (AI) technology to speed up drug development. The move will also see ex-Pfizer digital medicine executive Dr Daniel Karlin join the MindMed executive team, along with former Google AI guru Bradford Cross.

FDA 134
article thumbnail

AstraZeneca/Oxford to trial COVID-19 vaccine in children

Outsourcing Pharma

A new trial for the AstraZeneca/Oxford COVID-19 vaccine will investigate the efficacy of the vaccine in children aged six and over.

Vaccines 144
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How to Increase Your Webinar Engagement

Pharma Marketing Network

It’s 2019, your plane is booked, your outfits for the next three days are all planned out and packed away in your suitcase. You have a list of all of the presentations you plan on attending during the three-day pharmaceutical conference in New Orleans, and all of your lines have been practiced in front of a mirror for when you go to interview some of the keynote speakers.

article thumbnail

How to Make Stickers to Sell, Easy Tools, and 3 Steps to Follow

That Frugal Pharmacist

I started to sell stickers about 8 months ago and I thought it was finally time to tackle how to make stickers to sell online in a blog post! I touched on it, though somewhat haphazardly when I discussed some of my 2020 side hustles. Since then, my custom sticker business has turned into a … How to Make Stickers to Sell, Easy Tools, and 3 Steps to Follow Read More ».

59
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Haven: The strategy that didn’t fix healthcare

pharmaphorum

John Singer discusses the disbanding of Haven, the joint healthcare venture by Amazon, JP Morgan and Berkshire Hathaway, and the strategies that can help fix US healthcare. . “The market” was terrified when Warren Buffett, Jamie Dimon and Jeff Bezos got together to disrupt healthcare three years ago with the launch of Haven – in response to that news, healthcare stocks comprising a significant chunk of the $3.5 trillion health economy in the United States shed billions in value overnight.

Insurance 126
article thumbnail

Blockchain could accelerate drug development: Bloqcube

Outsourcing Pharma

With pharma firms seeking solutions to get products in the hands of patients faster, one company believes blockchain technology could provide answers.

113
113

More Trending

article thumbnail

How Much Do Twitch Streamers Make? How to Make Money Streaming

That Frugal Pharmacist

Hey, That Frugal Pharmacist here with an intro. Look, I don’t play a lot of video games. They’re enjoyable and I used to do it more, but they just require so much time. That being said, when I’m retired, I’m not opposed to monetizing hobbies. So, how much do Twitch streamers make? If you’re already … How Much Do Twitch Streamers Make?

52
article thumbnail

Alzheimer’s Research UK starts AI-based drug hunt with Exscientia

pharmaphorum

Medical charity Alzheimer’s Research UK has teamed up with artificial intelligence specialist Exscientia to find new drug treatments for the devastating neurodegenerative disease. . The alliance will see Exscientia work with the charity’s Oxford Drug Discovery Institute (ODDI) to find therapeutics that target the neuroinflammation associated with Alzheimer’s disease (AD), focusing in particular on the NLRP3 inflammasome pathway.

article thumbnail

Decentralized trials more pandemic-proof than traditional: study

Outsourcing Pharma

A study by two trial technology firms reportedly indicates that decentralized trials are outperforming on-site in recruitment, retention and other aspects.

104
104
article thumbnail

QS-21, the ‘Gold Standard’ of immune system activators used in Covid-19 and other vaccines to be presented by CEO Gaston Salinas at BIO CEO & Investor Conference

Pharma Mirror

A novel approach for ensuring the virtually unlimited production of QS-21, the ‘Gold Standard’ adjuvant for improving vaccine efficacy, will be the subject of an upcoming presentation at the BIO CEO & Investor Digital Conference, starting February 16. BSI is well- positioned to become the industry’s most reliable and cost-effective supplier of GMP quality QS-21 worldwide.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

How to Increase Your Virtual Engagement

Pharma Marketing Network

It’s 2019, your plane is booked, your outfits for the next three days are all planned out and packed away in your suitcase. You have a list of all of the presentations you plan on attending during the three-day pharmaceutical conference in New Orleans, and all of your lines have been practiced in front of a mirror for when you go to interview some of the keynote speakers.

article thumbnail

UK will start first COVID-19 challenge study “within a month”

pharmaphorum

Sometime within the next few weeks, young and healthy volunteers will be deliberately exposed to the COVID-19 coronavirus in the UK in what looks set to be the first study of its type worldwide. . The human challenge study has just secured ethics committee approval and will recruit up to 90 volunteers aged 18-30 years, according to the UK government, which is backing it with £33.6 million ($47 million) in funding.

Vaccines 118
article thumbnail

On-demand capabilities help drug developers in a pinch

Outsourcing Pharma

With demand for fast-tracking therapies, vaccines and other products increasing, companies like Azzur Group offer the ability to add capabilities quickly.

article thumbnail

When is the Best Time to Buy a TV?

That Frugal Pharmacist

Looking for deals is what makes shopping fun. The bigger the sale, the better- similarly – the bigger the TV, the better! Ok, ok, I know this isn’t really the type of post you might expect to see here. That Frugal Pharmacist hasn’t bought a new tv in like 10 years. But, you may be in … When is the Best Time to Buy a TV? Read More ».

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Interview #6: Hospital admission as an opportunity for deprescribing?

The deprescribing.org Blog

Recently the Canadian Journal of Hospital Pharmacy (CJHP) published an article where the question “Should hospital admission be used as an opportunity for deprescribing in older adults?” was fiercely debated. Today we interview two hospital pharmacists, Pam Howell ( GeriMedRisk , Ontario, Canada) and Lisa Richardson ( Saint-Vincent Hospital and Bruyère Deprescribing Research Team, Ontario, Canada) to get their thoughts on this question. .

article thumbnail

GSK expands coronavirus antibody tie-up to include potential flu therapies

pharmaphorum

GlaxoSmithKline is expanding a coronavirus antibody collaboration with US biotech Vir, to include potential therapies for flu and other respiratory viruses. The big UK pharma is already working with Vir on antibody therapies for coronaviruses, and already have the antibody VIR-7831 in clinical trials including the US National Institutes of Health-backed ACTIV-3 study.

112
112
article thumbnail

COVID-19 accelerating RWE use in clinical settings: ConcertAI

Outsourcing Pharma

A leader from the clinical data solutions firm explains how the challenges created by the pandemic have helped fuel creativity and innovation in studies.

68
article thumbnail

Indication Guides Dosing – Primidone and Escitalopram

Med Ed 101

There are numerous examples of where the indication guides dosing. It is important as a pharmacist to remember this when you see unusual doses. I wanted to share a couple of examples that I came across recently. Escitalopram When using psychiatric medications, we must recognize how important the diagnosis is. I was reviewing a medication […]. The post Indication Guides Dosing – Primidone and Escitalopram appeared first on Med Ed 101.

40
article thumbnail

CureVac’s COVID-19 vaccine begins rolling review with EMA

Pharma Times

CureVac’s CVnCoV is currently being investigated in a randomised, placebo-controlled Phase IIb/III clinical trial

article thumbnail

North Korea ‘launched cyber-attack on Pfizer for COVID-19 jab data’

pharmaphorum

A news agency is claiming that North Korea launched a cyber-attack on Pfizer in a bid to steal information about its BioNTech-partnered COVID-19 vaccine, citing South Korea’s National Intelligence Service (NIS). The Yonhap agency said the revelation was made during a closed-door meeting of the intelligence committee of South Korea’s National Assembly.

Vaccines 111
article thumbnail

Parexel, NeoGenomics partner on oncology genomics project

Outsourcing Pharma

The two companies will work to advance precision cancer medicine by harnessing genomics data in trial design, recruitment, site selection and other areas.

63
article thumbnail

Medications That Interfere With Continuous Glucose Monitoring

Med Ed 101

Technology continues to impact disease state management in remarkable ways. Monitoring of patients with diabetes is no exception. Both the American Diabetes Association and American Association of Clinical Endocrinologists/American College of Endocrinology make light of this in their most recent guidelines for usage of continuous glucose monitoring (CGM) devices.

40
article thumbnail

Kidney Research UK pledges support to Accelerate@Babraham initiative

Pharma Times

Accelerate@Babraham supports early-stage life sciences ventures within the Babraham Research Campus’ community

48
article thumbnail

No cooling off for pharma digital transformation in 2021

pharmaphorum

COVID-19 has already proved to be a digital accelerant for the pharmaceutical industry, sparking new ideas into life and lighting a fire underneath existing plans that had, in retrospect, yet to burn brightly. After a year in which the need for digital transformation in pharma reached white heat levels, the sector mustn’t cool off in 2021 and revert to business-as-usual.

109
109
article thumbnail

Quotient acquisition of Arcinova aimed at ‘streamlining’ early development process for biotech and pharma companies

Outsourcing Pharma

Quotient Sciences, a drug development and manufacturing accelerator with facilities in the UK and the US, has acquired Arcinova, a UK-based multiservice contract development and manufacturing organization (CDMO).

52
article thumbnail

Best OINTMENT or CREAM for insect bites

Druggist

For many customers, ointment or cream for insect bites is the first line of rescue in stings management. In this post, I will review the best ointment or cream for insect bites available over the counter and from pharmacies. I will also discuss alternative options for insect bites, mainly the use of antihistamines. As with many of my previous posts, I will base my recommendations on the evidence (if possible) and draw a conclusion. .

article thumbnail

EU approves Tukysa combo for advanced HER2-positive breast cancer

Pharma Times

In the HER2CLIMB trial, Tukysa-treated patients had a 46% reduction in the risk of cancer progression or death

50
article thumbnail

Could CRISPR cure HIV? US biotech Excision raises $60m to find out

pharmaphorum

US biotech Excision BioTherapeutics has raised $60 million to test a potential HIV cure in the clinic, which would use CRISPR technology to snip out the viral code from human cells and tissues. Once someone is infected with HIV it stays with them for life thanks to the retrovirus’s ability to inject its DNA code into the host. Snipping out this viral code with powerful CRISPR gene editing technology, which last year won Drs Emmanuelle Charpentier and Jennifer Doudna the Nobel Prize for chemistry

105
105
article thumbnail

AHA training aids researchers with heart-to-heart talks

Outsourcing Pharma

The American Heart Associationâs Heart of Communicating Science modules are designed to help experts break complex talk into easy-to-understand language.

article thumbnail

Maculus Therapeutix welcomes Privity FZ LLE and Prepares Capital Raise for Novel Drug Delivery Platform

Pharma Mirror

Maculus Therapeutix, a preclinical-stage biopharmaceutical company which has developed a SINGLE injection delivery platform for diseases such as wet AMD (Age-related Macular Degeneration) and DME (Diabetic Macular Edema) instead of the standard 8-12 monthly injections, is pleased to welcome Privity FZ LLE as a partner and advisor for upcoming fundraising activities.

FDA 52
article thumbnail

COVID-19 collaborations could ‘unlock’ the potential of the UK’s life sciences sector

Pharma Times

New report recommends continuing collaborations across the life sciences sector

53
article thumbnail

Roche and PatchAi partner on digital tool for cancer patients

pharmaphorum

Roche’s Italian subsidiary has joined forces with digital health startup PatchAi to roll out an app that aims to support people diagnosed with cancer. Roche and PatchAi have been working together on the Smart Health Companion (SHC), which was launched to oncology and haematology patients in July 2020, and will now step up their collaboration to offer it more widely.

article thumbnail

Imaging biomarkers driving clinical innovations: HealthMyne

Outsourcing Pharma

In the drive to advance personalized medicine, researchers are increasingly turning to radiomics to assist in the discovery of new types of biomarkers.

52
article thumbnail

Nektar lifted by Merck alliance for bempeg, new trial funding

pharmaphorum

Nektar Therapeutics is waiting on multiple data readouts for its lead drug bempegaldesleukin paired with strategic partner Bristol-Myers Squibb’s checkpoint inhibitor Opdivo, but that hasn’t stopped it signing up to test the drug with rival Keytruda from Merck & Co. . Merck will pair Keytruda (pembrolizumab) with bempegaldesleukin (NKTR-214) – known as bempeg for short – in a phase 2/3 trial involving patients with squamous cell carcinoma of the head and neck (SCCHN) that if positive could s

98